Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05709821
Title IMM60 and Pembrolizumab in Melanoma and NSCLC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors iOx Therapeutics
Age Groups: adult | senior
Covered Countries USA | GBR | ESP

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute - Medicine RECRUITING Boston Massachusetts 02215 United States Details
Henry Ford Hospital - Internal Medicine NOT_YET_RECRUITING Detroit Michigan 48202 United States Details
Rutgers, The State University of New Jersey - Robert Wood Johnson Medical School - The Cancer Institute of New Jersey (CINJ) RECRUITING New Brunswick New Jersey 08901 United States Details
Next VA NOT_YET_RECRUITING Fairfax Virginia 22031 United States Details
Institut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol NOT_YET_RECRUITING Badalona Barcelona 08916 Spain Details
Complexo Hospitalario Universitario A Coruña NOT_YET_RECRUITING A Coruña Galicia 15006 Spain Details
Hospital Xeral Álvaro Cunqueiro NOT_YET_RECRUITING Vigo Pontevedra 36312 Spain Details
Hospital de La Santa Creu i Sant Pau NOT_YET_RECRUITING Barcelona 08041 Spain Details
Hospital Universitario 12 de Octubre NOT_YET_RECRUITING Madrid 28041 Spain Details
Hospital Regional Universitario de Málaga NOT_YET_RECRUITING Málaga 29011 Spain Details
Hospital Universitario Virgen De La Macarena NOT_YET_RECRUITING Sevilla 41009 Spain Details
H. Clínico de Valencia NOT_YET_RECRUITING Valencia 46010 Spain Details
Nottingham University Hospital - Oncology NOT_YET_RECRUITING Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from for the field